D-cycloserine

D-cycloserine is a lipid of Polyketides (PK) class. D-cycloserine is associated with abnormalities such as Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis and Inflammatory Bowel Diseases. The involved functions are known as Cellular Infiltration, Vascular Permeability, Stimulus, antagonists and Kinase Inhibitors [MoA]. D-cycloserine often locates in Tissue membrane, Body tissue, Protoplasm, Endothelium and Cell Wall. The associated genes with D-cycloserine are Genome, serine O-sulfate, Polypeptides, alpha-aminobutyric acid, (S)-isomer and Genes, Reporter. The related lipids are Sphingolipids, Fatty Acids, Sterols, 25-hydroxycholesterol and Fatty Acids, Unsaturated.

Cross Reference

Introduction

To understand associated biological information of D-cycloserine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with D-cycloserine?

D-cycloserine is suspected in Tuberculosis, Inflammatory disorder, Asthma, Rheumatoid Arthritis, Multiple Sclerosis, Inflammatory Bowel Diseases and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with D-cycloserine

MeSH term MeSH ID Detail
Starvation D013217 47 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Total 2

PubChem Associated disorders and diseases

What pathways are associated with D-cycloserine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with D-cycloserine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with D-cycloserine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with D-cycloserine?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with D-cycloserine?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with D-cycloserine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with D-cycloserine

Download all related citations
Per page 10 20 50 100 | Total 2271
Authors Title Published Journal PubMed Link
pmid:16296047
Baghaei P et al. Adverse effects of multidrug-resistant tuberculosis treatment with a standardized regimen: a report from Iran. Am J Ther pmid:20019591
pmid:23342661
pmid:
Nadeau SE et al. A pilot randomized controlled trial of D-cycloserine and distributed practice as adjuvants to constraint-induced movement therapy after stroke. Neurorehabil Neural Repair pmid:24769437
Sharma B et al. Cycloserine-induced psychosis in a young female with drug-resistant tuberculosis. Gen Hosp Psychiatry pmid:24766906
CYCLOSERINE. 1955 Br Med J pmid:14363816
STEENKEN W and WOLINSKY E Cycloserine: antituberculous activity in vitro and in the experimental animal. 1956 Am Rev Tuberc pmid:13302684
NEILANDS JB Metal and hydrogen-ion binding properties of cycloserine. 1956 Arch. Biochem. Biophys. pmid:13314649
WOODSIDE JM et al. Spectrophotometric determination of cycloserine and isoniazid in pharmaceutical preparations. 1957 J Am Pharm Assoc Am Pharm Assoc pmid:13491492
HERROLD RD Some considerations in the administration of novobiocin and cycloserine. 1957 J. Urol. pmid:13439702
ANDREJEW A et al. [Effect of d-cycloserine & isonicotinic acid hydrazide on the catalase activity of Mycobacteria]. 1958 Biochim. Biophys. Acta pmid:13584402
HUGHES J et al. Cycloserine in chronic urinary infections. 1958 J. Urol. pmid:13564591
WEISERT O Some investigations relating to resistance determination of tubercle bacilli on cycloserine-containing Lowenstein-Jensen medium. 1958 Acta Pathol Microbiol Scand pmid:13532707
HEIN J and BERTHOLD H [On cycloserine-therapy]. 1959 Schweiz Z Tuberc Pneumonol pmid:14400685
HOLMES CX et al. The role of the cycloserine (seromycin) blood level in the treatment of pulmonary tuberculosis and the prevention and control of cycloserine (seromycin) toxicity. 1959 Dis Chest pmid:14402775
DUMON G [New antibiotics and pulmonary tuberculosis (viomycin, cycloserine, neomycin)]. 1959 Mars Med pmid:13818595
ROGNATO C et al. [Hematic levels of cycloserine in relation to seasonal temperature]. 1959 Arcisp S Anna Ferrara pmid:13854547
ROGNATO C and ZAMPINI N [Urinary elimination of cycloserine in man]. 1959 Arcisp S Anna Ferrara pmid:13854548
LEITES V Cycloserine-isoniazid in the ambulatory treatment of active tuberculosis after failure of previous chemotherapy. 1959 Am. Rev. Respir. Dis. pmid:13670395